Actionable news
0
All posts from Actionable news
Actionable news in SAGE: SAGE THERAPEUTICS INC,

Sage Therapeutics: Incorporated By Reference To Exhibit Description

The following excerpt is from the company's SEC filing.

Form or

Schedule

Exhibit

Filing

Date with

SEC File

Number

10.1*#

Exclusive License Agreement, by and between the Registrant and the Regents of the University of California, dated June 6, 2015.

31.1*

Certification of Principal Executive Officer pursuant to Exchange Act rules

13a-14

15d-14.

31.2*

Certification of Principal Financial Officer pursuant to Exchange Act rules

101.INS

XBRL Instance Document.

Form 10-Q

August 12, 2015

001-36544

101.SCH

XBRL Taxonomy Exte nsion Schema Document.

101.CAL

XBRL Taxonomy Extension Calculation Document.

101.DEF

XBRL...


More